ABSTRACT
Question In people with spinal cord injury, does exoskeleton-assisted walking training improve pulmonary ventilation function, motor function and related body structure, walking, and activities of daily life equally comparing those with conventional exercise program?
Design Randomised controlled trial with concealed allocation, assessor blinding and intention-to-treat analysis.
Intervention Both groups undertook 16 sessions of 50-60min training (4 days/week, 4 weeks). Participants in the experimental group received EAW trainings using AIDER system, which assisted standing, walking, and climbing the stairs. The control group received a conventional exercise program which combined aerobic, resistance, flexibility and walking training.
Outcome measures The primary outcome was the pulmonary function test. The secondary outcomes included: a 6-minute walk test with Borg scale (0 to 10) rating of exertion, 10-metre walk test, basic activities of daily living, trunk control test, lower extremity motor score, muscle tone of lower limb, bone mineral density, and distal femoral cartilage at baseline and upon completion of treatment.
Results After 4 weeks of trainings, the experimental group improved more on the forced vital capacity (MD 0.53, 95%CI 0.01 to 1.06), predicted FVC% (MD 19.59, 95%CI 6.63 to 32.54) and forced expiratory volume in 1s (MD 0.61, 95%CI 0.15 to 1.07); BADL (MD 19.75, 95%CI 10.88 to 28.62); and distal femoral cartilage than the control group. Participants completed 6-minute walk test with median 17.3 meters while wearing the exoskeleton. There was no difference in trunk control test, lower extremity motor score, muscle tone, bone mineral density and adverse event.
Conclusions In people with lower thoracic neurological level of spinal cord injury, exoskeleton-assisted walking training instead of a conventional excise program has potential benefits to facilitate pulmonary ventilation function, walking, basic activities of daily living and thickness of cartilage.
Trial registration ChiCTR2000034623
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ChiCTR2000034623
Funding Statement
This research study was supported by the National Key R&D Program of China (grant numbers 2017YFB1302305), the National Natural Science Foundation (81972146), the Department of Science and Technology of Sichuan Province (20YYJC3320 and 2020YJ0210).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
the medical ethics committee of West China Hospital of Sichuan University
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Setting: Department of Rehabilitation Medicine, West China Hospital of Sichuan University.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
